Radiology AI authorizations rise 42% as regulatory landscape evolvesmyappsplusOctober 1, 2026 A new analysis of the U.S. Food and Drug Administration’s artificial intelligence-enabled medical device database details how the technology’s regulatory standing has evolved in recent years.